FMR1 antibody (AA 36-279)
Quick Overview for FMR1 antibody (AA 36-279) (ABIN2721254)
Target
See all FMR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 36-279
-
Characteristics
- Homo sapiens fragile X mental retardation 1 (FMR1), transcript variant ISO1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 36-279 of human FMR1(NP_002015) produced in E.coli.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- WB 1:500~2000, IHC 1:50,
-
Comment
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
-
Alternative Name
- FMR1
-
Background
- The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene.
-
Molecular Weight
- 71 kDa
-
Gene ID
- 2332
-
NCBI Accession
- NM_002024
-
HGNC
- 2332
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-